跳至主要内容
临床试验/NCT00543920
NCT00543920已完成2 期

A Study of MK0777 in the Treatment of Outpatients With Generalized Anxiety Disorder (0777-020)

Merck Sharp & Dohme LLC0 个研究点目标入组 60 人开始时间: 2002年8月最近更新:
适应症
相关药物

试验速览

阶段
2 期
状态
已完成
入组人数
60

研究概览

简要总结

The study will look at the effect of MK0777on reducing anxiety in subjects with general anxiety disorder.

This is an early phase trial and some specific protocol information is in progress and not publicly available at this time. (Full information is available to trial participants).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Diagnosis of General Anxiety Order

排除标准

  • Women who are pregnant or breast-feeding
  • History of severe drug reaction
  • History of severe drug withdrawal symptoms such as seizures or delirium
  • Disease of cardiovascular system
  • Disease of the liver, kidneys, endocrine system, metabolic system or eyes
  • History of seizures or seizure disorder
  • History of drug or alcohol abuse

研究者

申办方类型
Industry
责任方
Sponsor

相似试验